Enhanced oral insulin delivery with charge-reversible lipid nanoparticles

被引:0
|
作者
Oyama, Dai [1 ,2 ]
Matayoshi, Katsuki [1 ]
Kanetaka, Soya [1 ]
Nitta, Chiori [1 ]
Koide, Hiroyuki [1 ]
Minami, Keiko [3 ]
Asai, Tomohiro [1 ]
机构
[1] Univ Shizuoka, Lab Med Biochem, Sch Pharmaceut Sci, 52-1 Yada,Suruga Ku, Shizuoka 4228526, Japan
[2] Astellas Pharma Inc, CMC Prod Management, PPM JP1, 2-5-1 Nihonbashi Honcho,Chuo Ku, Tokyo 1038411, Japan
[3] Setsunan Univ, Fac Pharmaceut Sci, 45-1 Nagaotoge Cho, Hirakata, Osaka 5730101, Japan
关键词
Dioleoylglycerophosphate-diethylenediamine; Charge-reversible; Lipid nanoparticles; Oral insulin delivery; pH-responsive; Streptozocin-induced diabetic mice; LIPOSOMES;
D O I
10.1016/j.bbrc.2025.151420
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oral insulin has therapeutic advantages, as it can mimic the endogenous insulin pathway and relieve patients from daily self-injections. Among the many investigated oral insulin delivery systems, lipid nanoparticle (LNP)-based drug delivery systems are considered promising platforms for improving oral insulin absorption due to their unique in vivo properties and high design flexibility. However, challenges such as toxicity and low oral bioavailability persist. Dioleoylglycerophosphate-diethylenediamine (DOP-DEDA) is a pH-responsive and charge-reversible lipid for cytosolic cargo delivery. In this study, an insulin-encapsulated DOP-DEDA-based LNP (Ins-LNP) system was developed to achieve highly biocompatible and efficient oral insulin delivery. The Ins-LNPs exhibited a positive charge at gastrointestinal pH levels of 1.2 and 6.8, suggesting enhanced stability in the acidic stomach environment and facilitating efficient absorption in the small intestine. In addition, they are noncationic at a physiological pH level of 7.4, indicating low toxicity. PEGylated Ins-LNPs had a particle size of 125.4 nm, a polydispersity index of 0.047, and an encapsulation efficiency of 57.2 %. PEGylated Ins-LNPs maintained their particle characteristics for more than 2 h in simulated gastrointestinal fluid containing digestive enzymes. They also retained 89 %, 51 %, and 44 % of insulin for 60 min in simulated gastrointestinal/physiological fluid at pH levels of 1.2, 6.8, and 7.4, respectively. Furthermore, in vivo studies using streptozocin-induced diabetic mice demonstrated a pronounced and sustained hypoglycemic effect following oral administration, characterized by a similar to 40 % reduction in blood glucose levels for over 10 h, indicative of an optimal pharmacodynamic profile. This favorable pharmacodynamic profile may mitigate the risk of clinically relevant hypoglycemia, enhancing patient compliance and overall treatment outcomes. Consequently, this research presents a promising LNP system for oral insulin delivery.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Nanoparticles enable oral insulin delivery in mice
    Satyanarayana, Megha
    CHEMICAL & ENGINEERING NEWS, 2019, 97 (45) : 7 - 7
  • [42] Polymeric nanoparticles (PNPs) for oral delivery of insulin
    Wang, Yunyun
    Li, Hao
    Rasool, Aamir
    Wang, Hebin
    Manzoor, Robina
    Zhang, Genlin
    JOURNAL OF NANOBIOTECHNOLOGY, 2024, 22 (01)
  • [43] Oral Insulin Delivery by Chitosan Coated Solid Lipid Nanoparticles: Ex vivo and in vivo Studies
    Anchan, Rakshitha Bhaskar
    Koland, Marina
    JOURNAL OF YOUNG PHARMACISTS, 2021, 13 (01) : 43 - 48
  • [44] Surface Charge-Reversible Tubular Micromotors for Extraction of Nucleic Acids in Microsystems
    Luo, Ming
    Jiang, Yuzhou
    Su, Jingbei
    Deng, Zhuoyi
    Mou, Fangzhi
    Xu, Leilei
    Guan, Jianguo
    CHEMISTRY-AN ASIAN JOURNAL, 2019, 14 (14) : 2503 - 2511
  • [45] Mesoporous silica nanoparticles with redox-responsive surface linkers for charge-reversible loading and release of short oligonucleotides
    Zhang, Jixi
    Niemela, Minna
    Westermarck, Jukka
    Rosenholm, Jessica M.
    DALTON TRANSACTIONS, 2014, 43 (10) : 4115 - 4126
  • [46] Smart hypoxia-responsive transformable and charge-reversible nanoparticles for the deep penetration and tumor microenvironment modulation of pancreatic cancer
    Chen, Hongyi
    Guo, Qin
    Chu, Yongchao
    Li, Chao
    Zhang, Yiwen
    Liu, Peixin
    Zhao, Zhenhao
    Wang, Yu
    Luo, Yifan
    Zhou, Zheng
    Zhang, Tongyu
    Song, Haolin
    Li, Xuwen
    Li, Chufeng
    Su, Boyu
    You, Haoyu
    Sun, Tao
    Jiang, Chen
    BIOMATERIALS, 2022, 287
  • [47] Solid lipid nanoparticles: a promising tool for insulin delivery
    Mohammadpour, Fatemeh
    Kamali, Hossein
    Gholami, Leila
    McCloskey, Alice P.
    Kesharwani, Prashant
    Sahebkar, Amirhossein
    EXPERT OPINION ON DRUG DELIVERY, 2022, 19 (12) : 1577 - 1595
  • [48] Exploring the potential of functional polymer-lipid hybrid nanoparticles for enhanced oral delivery of paclitaxel
    Qin, Lu
    Wu, Haiyang
    Xu, Enyu
    Zhang, Xin
    Guan, Jian
    Zhao, Ruizhi
    Mao, Shirui
    ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 16 (03) : 387 - 395
  • [49] Exploring the potential of functional polymer-lipid hybrid nanoparticles for enhanced oral delivery of paclitaxel
    Lu Qin
    Haiyang Wu
    Enyu Xu
    Xin Zhang
    Jian Guan
    Ruizhi Zhao
    Shirui Mao
    AsianJournalofPharmaceuticalSciences, 2021, 16 (03) : 387 - 395
  • [50] Dual crosslinking of folic acid-modified pectin nanoparticles for enhanced oral insulin delivery
    Zhang, Fenglei
    Pei, Xuejing
    Peng, Xiaoxia
    Gou, Dongxia
    Fan, Xiao
    Zheng, Xuefei
    Song, Chengcheng
    Zhou, Yifa
    Cui, Sisi
    BIOMATERIALS ADVANCES, 2022, 135